Versor Investments LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versor Investments LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$713,505
+93.7%
7,965
+84.1%
0.14%
+125.0%
Q2 2023$368,316
-29.6%
4,326
-31.5%
0.06%
-7.2%
Q1 2023$522,897
-42.7%
6,319
-45.5%
0.07%
-11.5%
Q4 2022$912,340
+168.3%
11,600
+152.7%
0.08%
+290.0%
Q3 2022$340,000
+57.4%
4,591
+112.8%
0.02%
-60.0%
Q4 2018$216,000
-60.4%
2,157
-54.7%
0.05%
-75.5%
Q3 2018$545,000
+30.4%
4,757
+2.1%
0.20%
+44.7%
Q2 2018$418,000
+22.6%
4,6570.0%0.14%
+22.6%
Q1 2018$341,0004,6570.12%
Other shareholders
HAEMONETICS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders